Academic & Research Hospital Drug Developers
As a cross-sector partnership between industry, academia, and research hospitals, Landmark Bio is uniquely positioned to support translating your research from concept to clinic. We work with partners to plan and execute their research, IND-enabling and clinical manufacturing aspirations within their budgetary and resource means. Landmark Bio has developed a series of tailored service offerings designed around our academic and research hospital partners to translate academic protocols into the clinic through our services spanning drug development consulting, process/analytical development, cGMP manufacturing and CMC regulatory consulting.
Start-up & Established Industry Drug Developers
Landmark Bio was founded by drug developers and understands the urgency of industrial drug development. We leverage our deep drug development expertise, combined with our flexible partnership models, to reinvent the way drug developers collaborate with CDMO’s by tailoring collaborations to meet our clients where they’re at in their drug development journey. Whether you’re in early development and need IND-enabling services or accelerating towards commercialization, Landmark Bio has a partnership model and package for you.
Learn more about our services
As an advanced therapy CDMO we help you achieve your ultimate clinical and commercial aspirations.
Landmark Bio’s Philosophy to Partnering
Landmark Bio was born from the idea that there is a better way to partner and collaborate with CDMOs. We’ve drawn from our own drug development experiences to reinvent the partnership model with the drug developer’s objectives, needs and goals in mind. Our partnering philosophy is built upon Transparency, Collaboration, Flexibility & Agility, and Reliability.
Transparency
We believe in full transparency and real-time communication. Landmark Bio provides access to raw data, not solely reports and summaries. Transparency enables the combined abilities of your deep scientific and program knowledge and Landmark Bio’s CMC expertise to overcome technical challenges. This partnership is enabled through joint project teams, and together the team develops the initial project plan and manages the project to completion.
Collaboration
We believe in strong collaboration between our clients and our staff. Clients are highly encouraged to work alongside our staff in the laboratory and cGMP suite to ensure your program timeline and objectives.
Flexibility
We understand the need to be flexible throughout the drug development and commercialization journey. Landmark Bio has adopted an operating model which enables our technical teams to quickly adjust to modified project plans to meet your program needs and objectives.
Agility
We dedicate ourselves to operating in an agile fashion, adjusting to your program’s timeline and ensuring project initiation, execution and completion on time.
Reliability
We hold ourselves responsible for meeting your program timelines and objectives. As drug developers, we commit ourselves to meeting your program objectives in accordance with an aligned project timeline.